MBBS

Xl Health Corporation India Private Limited is a 100% owned subsidiary of Xl Health US. XLHealth, US was founded in 1997. XLHealth,U.S has a proud history as an industry leader in improving the quality of care for chronically ill Medicare beneficiaries through care management services. XLHealth is a US$2 Billion company operating in 5 states of United States.

National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier research institute of the Indian Council of Medical Research (ICMR). It is situated in the vicinity of a number of hospitals and research institutes in central Mumbai.

Fresher Post Graduate in Pharmacy / Chemistry invited as Associate Scientist in CavinKare

Piramal Life Sciences Limited (PLSL) is an independent research-driven drug company that was recently demerged from Piramal Healthcare Limited (Formerly known as Nicholas Piramal India Limited). PLSL was formerly the NCE R&D division of NPIL.

April 2012

Cactus Communications—a company dedicated to the pursuit of good English. We provide editing, educational, transcription, and training services to individual and institutional clients worldwide. All our businesses are linked together by one common factor—great written English.

To achieve self-reliance, poor communities need answers to questions like: How can we grow more and healthier food? Protect our health? Create jobs? A key part of Canada’s aid program since 1970, IDRC supports research in developing countries to answer these questions.
IDRC also encourages sharing this knowledge with policymakers, other researchers, and communities around the world. The result is innovative, lasting local solutions that aim to bring choice and change to those who need it most.

Sun Pharma Advanced Research Company Ltd. (SPARC Ltd.) is India's first listed international pharma research and development company engaged in R&D of NCE (New Chemical Entities) and NDDS (New Drug Delivery Systems). It has a strong team of scientists focusing on projects that earn intellectual property and are meant for the world markets. Extensive clinical trials are ongoing for some of the NDDS which have reached Indian market and are poised for international markets.